Climate Pharma

Best Agrolife gets Indian patent for fungicidal composition

HQ Team October 31, 2022: Best Agrolife, a BSE-listed company, announced that its subsidiary had received a patent from the Indian government to.

Read More
Drugs Pharma

EMA cracks the whip on JAK inhibitors for inflammatory disorders

The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.

Read More
Health Pharma

2seventy bio, China’s JW Therapeutics sign pact for cancer therapy

2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based.

Read More
Pharma

Glenmark’s India facility gets ‘import alert’ from USFDA

Glenmark Pharmaceuticals, an Indian biopharmaceutical company, has received an "import alert" from USFDA for its Baddi facility in Himachal Pradesh.

Read More
Drugs Pharma

Alembic gets USFDA nod for oncology injection Paclitaxel

Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.

Read More
Health Pharma

Tuberculosis claims 1.6 million people in 2021, WHO says

Tuberculosis, the second deadliest infectious killer after Covid-19, claimed 1.6 million lives last year, including 187,000 HIV-positive patients, according to the WHO's 2022.

Read More
Drugs Pharma

J&J gets FDA approval for therapy to treat blood cancer

J &J gets approval from FDA for medicine to treat a type of blood cancer-Multiple Myeloma

Read More
Drugs Pharma

Aurobindo to recall two drugs with potential cancer risk

HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.

Read More
Drugs Medical Pharma

Pfizer expected to charge quadruple for Covid vaccines in the US

Pfizer set to increase Covid-19 vaccine prices by almost four times in the US

Read More
Pharma

Philips to slash 4,000 jobs as respirator recall slump sales

HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of.

Read More